Drug Profile
Research programme: cancer therapeutics - Cloud Pharmaceuticals/University of Florida College of Medicine
Alternative Names: 8-oxodGTPase inhibitors - Cloud Pharmaceuticals/University of Florida College of Medicine; MTH1 protein inhibitors - Cloud Pharmaceuticals/University of Florida College of Medicine; MutT homolog 1 protein inhibitors - Cloud Pharmaceuticals/University of Florida College of MedicineLatest Information Update: 28 Apr 2019
Price :
$50
*
At a glance
- Originator Cloud Pharmaceuticals; University of Florida College of Medicine
- Class Small molecules
- Mechanism of Action 8-oxodGTPase inhibitors; Protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer